Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia

Published:2016-09-15 Issue:11 Volume:375 Page:1044-1053
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Maury Sébastien,Chevret Sylvie,Thomas Xavier,Heim Dominik,Leguay Thibaut,Huguet Françoise,Chevallier Patrice,Hunault Mathilde,Boissel Nicolas,Escoffre-Barbe Martine,Hess Urs,Vey Norbert,Pignon Jean-Michel,Braun Thorsten,Marolleau Jean-Pierre,Cahn Jean-Yves,Chalandon Yves,Lhéritier Véronique,Beldjord Kheira,Béné Marie C.,Ifrah Norbert,Dombret Hervé

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1605085

Cited by 283 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The significance of CD49f expression in pediatric B-cell acute lymphoblastic leukemia;American Journal of Clinical Pathology;2024-09-11

2. Need for consensus on primary end points and efficacy definitions in trials for adult acute lymphoblastic leukemia;Blood Advances;2024-08-13

3. Immunotherapy in first line treatment of adult acute lymphoblastic leukemia;Current Opinion in Oncology;2024-08-13

4. The Outcome of Modified St. Jude Total XV Protocol in Turkish Children with Newly Diagnosed Acute Lymphoblastic Leukemia: A Single-Center Retrospective Analysis;Turkish Journal of Hematology;2024-08-05

5. Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL);Current Treatment Options in Oncology;2024-08-05